

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ribosomal small subunit assembly (GO:0000028) | 6.59259984 |
| 2 | proline biosynthetic process (GO:0006561) | 5.72728330 |
| 3 | DNA deamination (GO:0045006) | 5.43098729 |
| 4 | viral transcription (GO:0019083) | 5.34899104 |
| 5 | translational termination (GO:0006415) | 5.11112505 |
| 6 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.93709750 |
| 7 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 4.86287288 |
| 8 | ribosomal small subunit biogenesis (GO:0042274) | 4.84170191 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 4.81893981 |
| 10 | protein targeting to ER (GO:0045047) | 4.80616331 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.68031258 |
| 12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.55063860 |
| 13 | protein localization to endoplasmic reticulum (GO:0070972) | 4.54524914 |
| 14 | snRNA metabolic process (GO:0016073) | 4.48716428 |
| 15 | translational elongation (GO:0006414) | 4.48433169 |
| 16 | peptidyl-arginine omega-N-methylation (GO:0035247) | 4.41158364 |
| 17 | negative regulation of cell size (GO:0045792) | 4.26426692 |
| 18 | Golgi transport vesicle coating (GO:0048200) | 4.25562993 |
| 19 | COPI coating of Golgi vesicle (GO:0048205) | 4.25562993 |
| 20 | maturation of SSU-rRNA (GO:0030490) | 4.08801609 |
| 21 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.06317426 |
| 22 | viral life cycle (GO:0019058) | 4.04893002 |
| 23 | snRNA processing (GO:0016180) | 4.00460924 |
| 24 | apoptotic process involved in morphogenesis (GO:0060561) | 4.00300820 |
| 25 | proline metabolic process (GO:0006560) | 3.92636286 |
| 26 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.90897215 |
| 27 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.89269575 |
| 28 | cellular protein complex disassembly (GO:0043624) | 3.84510093 |
| 29 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.82642997 |
| 30 | translational initiation (GO:0006413) | 3.80839221 |
| 31 | modulation by virus of host process (GO:0019054) | 3.66672112 |
| 32 | mannose metabolic process (GO:0006013) | 3.64290603 |
| 33 | DNA strand elongation (GO:0022616) | 3.64245910 |
| 34 | GDP-mannose metabolic process (GO:0019673) | 3.63647412 |
| 35 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.62443696 |
| 36 | telomere maintenance via recombination (GO:0000722) | 3.61735993 |
| 37 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.61088315 |
| 38 | histone arginine methylation (GO:0034969) | 3.60186773 |
| 39 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.54227338 |
| 40 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.53483294 |
| 41 | modulation by symbiont of host cellular process (GO:0044068) | 3.53314361 |
| 42 | regulation of chromatin binding (GO:0035561) | 3.52190366 |
| 43 | ribosomal large subunit biogenesis (GO:0042273) | 3.50546915 |
| 44 | pentose-phosphate shunt (GO:0006098) | 3.45174069 |
| 45 | semaphorin-plexin signaling pathway (GO:0071526) | 3.43435699 |
| 46 | peptidyl-arginine methylation (GO:0018216) | 3.42636846 |
| 47 | peptidyl-arginine N-methylation (GO:0035246) | 3.42636846 |
| 48 | planar cell polarity pathway involved in neural tube closure (GO:0090179) | 3.40646510 |
| 49 | protein retention in ER lumen (GO:0006621) | 3.38451355 |
| 50 | protein complex disassembly (GO:0043241) | 3.35334841 |
| 51 | protein-DNA complex disassembly (GO:0032986) | 3.33410676 |
| 52 | nucleosome disassembly (GO:0006337) | 3.33410676 |
| 53 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.31773691 |
| 54 | UV protection (GO:0009650) | 3.30269456 |
| 55 | translation (GO:0006412) | 3.29868156 |
| 56 | mitotic recombination (GO:0006312) | 3.28213122 |
| 57 | adherens junction assembly (GO:0034333) | 3.27337696 |
| 58 | proteasome assembly (GO:0043248) | 3.27198645 |
| 59 | protein localization to endosome (GO:0036010) | 3.25739498 |
| 60 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.24965106 |
| 61 | protein insertion into membrane (GO:0051205) | 3.23935902 |
| 62 | DNA replication initiation (GO:0006270) | 3.19809774 |
| 63 | focal adhesion assembly (GO:0048041) | 3.17751110 |
| 64 | cell-substrate adherens junction assembly (GO:0007045) | 3.17751110 |
| 65 | macromolecular complex disassembly (GO:0032984) | 3.17001546 |
| 66 | regulation of translational fidelity (GO:0006450) | 3.14824135 |
| 67 | protein targeting to membrane (GO:0006612) | 3.14333804 |
| 68 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.12990080 |
| 69 | glucose catabolic process (GO:0006007) | 3.11612546 |
| 70 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.10473545 |
| 71 | activation of Rac GTPase activity (GO:0032863) | 3.10411628 |
| 72 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.06777596 |
| 73 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.06777596 |
| 74 | mitotic chromosome condensation (GO:0007076) | 3.03332878 |
| 75 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.03049612 |
| 76 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 3.03023898 |
| 77 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.02043730 |
| 78 | regulation of establishment of planar polarity involved in neural tube closure (GO:0090178) | 3.02012714 |
| 79 | regulation of early endosome to late endosome transport (GO:2000641) | 3.00368507 |
| 80 | nuclear envelope reassembly (GO:0031468) | 2.98490427 |
| 81 | mitotic nuclear envelope reassembly (GO:0007084) | 2.98490427 |
| 82 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.96794080 |
| 83 | signal peptide processing (GO:0006465) | 2.95854907 |
| 84 | telomere maintenance via telomere lengthening (GO:0010833) | 2.93415855 |
| 85 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.92276581 |
| 86 | cellular response to virus (GO:0098586) | 2.92154942 |
| 87 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.92033891 |
| 88 | adenine nucleotide transport (GO:0051503) | 2.90654069 |
| 89 | mRNA catabolic process (GO:0006402) | 2.90331520 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.88098352 |
| 91 | NADPH regeneration (GO:0006740) | 2.86402729 |
| 92 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.85616420 |
| 93 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83644793 |
| 94 | folic acid metabolic process (GO:0046655) | 2.83422946 |
| 95 | maternal placenta development (GO:0001893) | 2.83172357 |
| 96 | RNA catabolic process (GO:0006401) | 2.78977992 |
| 97 | modulation by virus of host morphology or physiology (GO:0019048) | 2.78513437 |
| 98 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.77470208 |
| 99 | NIK/NF-kappaB signaling (GO:0038061) | 2.77294929 |
| 100 | neutrophil activation involved in immune response (GO:0002283) | 2.76870400 |
| 101 | formation of translation preinitiation complex (GO:0001731) | 2.74883976 |
| 102 | response to interferon-beta (GO:0035456) | 2.73849344 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.73007555 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.70358143 |
| 105 | DNA replication checkpoint (GO:0000076) | 2.69135670 |
| 106 | urea cycle (GO:0000050) | 2.66431373 |
| 107 | activation of MAPKKK activity (GO:0000185) | 2.65460849 |
| 108 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.65172883 |
| 109 | pentose metabolic process (GO:0019321) | 2.64141296 |
| 110 | regulation of histone H3-K27 methylation (GO:0061085) | 2.62721812 |
| 111 | negative regulation of viral release from host cell (GO:1902187) | 2.62306930 |
| 112 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.62069038 |
| 113 | embryonic process involved in female pregnancy (GO:0060136) | 2.60150723 |
| 114 | mRNA stabilization (GO:0048255) | 2.59855251 |
| 115 | RNA stabilization (GO:0043489) | 2.59855251 |
| 116 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.59515541 |
| 117 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.58769250 |
| 118 | DNA unwinding involved in DNA replication (GO:0006268) | 2.57788686 |
| 119 | positive regulation of nuclease activity (GO:0032075) | 2.57485727 |
| 120 | leukocyte aggregation (GO:0070486) | 2.57199524 |
| 121 | immunoglobulin mediated immune response (GO:0016064) | 2.57113912 |
| 122 | adenosine receptor signaling pathway (GO:0001973) | 2.57089605 |
| 123 | rRNA transcription (GO:0009303) | 2.56510978 |
| 124 | heterochromatin organization (GO:0070828) | 2.55600960 |
| 125 | cellular response to interferon-beta (GO:0035458) | 2.55553901 |
| 126 | rRNA processing (GO:0006364) | 2.55114673 |
| 127 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.55110187 |
| 128 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.53317624 |
| 129 | stress fiber assembly (GO:0043149) | 2.53208743 |
| 130 | protein complex localization (GO:0031503) | 2.53164382 |
| 131 | regulation of protein heterodimerization activity (GO:0043497) | 2.52362241 |
| 132 | activation of JUN kinase activity (GO:0007257) | 2.52065728 |
| 133 | L-serine metabolic process (GO:0006563) | 2.51575291 |
| 134 | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 2.51417645 |
| 135 | apoptotic process involved in development (GO:1902742) | 2.51180261 |
| 136 | NADH metabolic process (GO:0006734) | 2.50852305 |
| 137 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.49991360 |
| 138 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.49644988 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.49188602 |
| 140 | pseudouridine synthesis (GO:0001522) | 2.49168720 |
| 141 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49114326 |
| 142 | tricarboxylic acid metabolic process (GO:0072350) | 2.48810132 |
| 143 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.47425196 |
| 144 | negative regulation of myotube differentiation (GO:0010832) | 2.46901451 |
| 145 | glucose 6-phosphate metabolic process (GO:0051156) | 2.46839920 |
| 146 | cell-cell junction maintenance (GO:0045217) | 2.46823008 |
| 147 | regulation of cholesterol metabolic process (GO:0090181) | 2.46778938 |
| 148 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241) | 2.46621708 |
| 149 | rRNA metabolic process (GO:0016072) | 2.46448420 |
| 150 | mitochondrial fusion (GO:0008053) | 2.46399054 |
| 151 | monosaccharide biosynthetic process (GO:0046364) | 2.46267004 |
| 152 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45676849 |
| 153 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.45253379 |
| 154 | positive regulation of B cell differentiation (GO:0045579) | 2.44767105 |
| 155 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.44368365 |
| 156 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.44328315 |
| 157 | purine ribonucleotide transport (GO:0015868) | 2.43268925 |
| 158 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42958780 |
| 159 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.42958780 |
| 160 | pinocytosis (GO:0006907) | 2.42464790 |
| 161 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.40756429 |
| 162 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.40756429 |
| 163 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.40756429 |
| 164 | DNA duplex unwinding (GO:0032508) | 2.40611597 |
| 165 | iron-sulfur cluster assembly (GO:0016226) | 2.39816382 |
| 166 | metallo-sulfur cluster assembly (GO:0031163) | 2.39816382 |
| 167 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.39630412 |
| 168 | basement membrane organization (GO:0071711) | 2.39524539 |
| 169 | B cell mediated immunity (GO:0019724) | 2.39479339 |
| 170 | telomere organization (GO:0032200) | 2.38709234 |
| 171 | telomere maintenance (GO:0000723) | 2.38240453 |
| 172 | chromatin remodeling at centromere (GO:0031055) | 2.36858290 |
| 173 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.35432920 |
| 174 | cellular component biogenesis (GO:0044085) | 2.35146644 |
| 175 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.34587037 |
| 176 | termination of RNA polymerase III transcription (GO:0006386) | 2.34587037 |
| 177 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.34327037 |
| 178 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.33219781 |
| 179 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.32070120 |
| 180 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.32070120 |
| 181 | platelet dense granule organization (GO:0060155) | 2.30741178 |
| 182 | T cell apoptotic process (GO:0070231) | 2.30164358 |
| 183 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.30041245 |
| 184 | negative regulation of ligase activity (GO:0051352) | 2.30041245 |
| 185 | somatic recombination of immunoglobulin genes involved in immune response (GO:0002204) | 2.29021820 |
| 186 | somatic diversification of immunoglobulins involved in immune response (GO:0002208) | 2.29021820 |
| 187 | isotype switching (GO:0045190) | 2.29021820 |
| 188 | respiratory burst (GO:0045730) | 2.28994069 |
| 189 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.28775701 |
| 190 | heme biosynthetic process (GO:0006783) | 2.28716994 |
| 191 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.27466153 |
| 192 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.27096314 |
| 193 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.26507582 |
| 194 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.25837558 |
| 195 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.25376348 |
| 196 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.24806302 |
| 197 | defense response to protozoan (GO:0042832) | 2.23582037 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.79805826 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.34090838 |
| 3 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.18248822 |
| 4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.09136633 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.89587532 |
| 6 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.79971677 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.77659523 |
| 8 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.72603360 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.65025449 |
| 10 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.63878882 |
| 11 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.62110121 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.56361012 |
| 13 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.46051702 |
| 14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.35352210 |
| 15 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.34579183 |
| 16 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.33468811 |
| 17 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27939922 |
| 18 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.24918224 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.23566545 |
| 20 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22651456 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.22556494 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.21182408 |
| 23 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.20654709 |
| 24 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.19245859 |
| 25 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.16763737 |
| 26 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.12155706 |
| 27 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08238443 |
| 28 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.06720822 |
| 29 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.04986813 |
| 30 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.03199196 |
| 31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.99973868 |
| 32 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.98230648 |
| 33 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.97531323 |
| 34 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.97136704 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.95757144 |
| 36 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.92720835 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.92541534 |
| 38 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.92472291 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.90250905 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.88865469 |
| 41 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88304624 |
| 42 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.88016926 |
| 43 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.87042983 |
| 44 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.84679079 |
| 45 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.81642189 |
| 46 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.79847620 |
| 47 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.77358675 |
| 48 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.76613155 |
| 49 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.76536607 |
| 50 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.76370358 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.74232717 |
| 52 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73875179 |
| 53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.72934474 |
| 54 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.72656095 |
| 55 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69403348 |
| 56 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.69357226 |
| 57 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.69054092 |
| 58 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66379245 |
| 59 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.65448407 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.64646221 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.64311428 |
| 62 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.61281499 |
| 63 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60983934 |
| 64 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.60377441 |
| 65 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.60327169 |
| 66 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.60101148 |
| 67 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.58362684 |
| 68 | GATA1_22025678_ChIP-Seq_K562_Human | 1.57668863 |
| 69 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.57016996 |
| 70 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.56967251 |
| 71 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.52925453 |
| 72 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.48878563 |
| 73 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.48501205 |
| 74 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.47498109 |
| 75 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.46004713 |
| 76 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.45798259 |
| 77 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43740105 |
| 78 | KDM2B_26808549_Chip-Seq_K562_Human | 1.42929864 |
| 79 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.42583738 |
| 80 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.42377901 |
| 81 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.42117946 |
| 82 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.40753617 |
| 83 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38812480 |
| 84 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.38351789 |
| 85 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.38234413 |
| 86 | MYC_22102868_ChIP-Seq_BL_Human | 1.38162096 |
| 87 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.36386752 |
| 88 | * SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34508758 |
| 89 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.34284074 |
| 90 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.34244875 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.34195672 |
| 92 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.33344334 |
| 93 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.33256574 |
| 94 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.32516086 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.32057729 |
| 96 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.31956341 |
| 97 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.31152196 |
| 98 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31078122 |
| 99 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.30905454 |
| 100 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30614351 |
| 101 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.28967530 |
| 102 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.28472667 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.27174558 |
| 104 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.25620470 |
| 105 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25535496 |
| 106 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.24257041 |
| 107 | MYB_26560356_Chip-Seq_TH2_Human | 1.23306677 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.22861189 |
| 109 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.22679350 |
| 110 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.22227484 |
| 111 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.21805005 |
| 112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.21005183 |
| 113 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20692001 |
| 114 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.20619952 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.19844848 |
| 116 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19018696 |
| 117 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.18508732 |
| 118 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.18247083 |
| 119 | MAF_26560356_Chip-Seq_TH1_Human | 1.18072012 |
| 120 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.17235703 |
| 121 | * CTCF_21964334_Chip-Seq_Bcells_Human | 1.16933968 |
| 122 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16887977 |
| 123 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16681722 |
| 124 | * NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.15319621 |
| 125 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.15306877 |
| 126 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14862390 |
| 127 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.14615049 |
| 128 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.14450356 |
| 129 | * RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.13719523 |
| 130 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13567234 |
| 131 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.12724701 |
| 132 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.12615713 |
| 133 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.12448938 |
| 134 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.11431867 |
| 135 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11425213 |
| 136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10952287 |
| 137 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.10635110 |
| 138 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.10406730 |
| 139 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09813667 |
| 140 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.09777341 |
| 141 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.09236864 |
| 142 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09134545 |
| 143 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.09134305 |
| 144 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.08979446 |
| 145 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08743631 |
| 146 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.08723505 |
| 147 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.08157931 |
| 148 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.07911168 |
| 149 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.07778272 |
| 150 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.07773182 |
| 151 | MYB_26560356_Chip-Seq_TH1_Human | 1.07680692 |
| 152 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07596782 |
| 153 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.07083763 |
| 154 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.07025812 |
| 155 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.06980807 |
| 156 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.06793097 |
| 157 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.06768196 |
| 158 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.06615123 |
| 159 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05223544 |
| 160 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.04128144 |
| 161 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.03515654 |
| 162 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.02295797 |
| 163 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.01139174 |
| 164 | UTX_26944678_Chip-Seq_JUKART_Human | 1.00988734 |
| 165 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.99209845 |
| 166 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98385268 |
| 167 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.97803191 |
| 168 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97649823 |
| 169 | MAF_26560356_Chip-Seq_TH2_Human | 0.93250638 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003705_abnormal_hypodermis_morpholog | 4.23808290 |
| 2 | MP0005451_abnormal_body_composition | 4.04135744 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.35735835 |
| 4 | MP0005076_abnormal_cell_differentiation | 3.12420751 |
| 5 | MP0003693_abnormal_embryo_hatching | 3.10400134 |
| 6 | MP0004185_abnormal_adipocyte_glucose | 2.76164272 |
| 7 | MP0005671_abnormal_response_to | 2.73173491 |
| 8 | MP0009785_altered_susceptibility_to | 2.63035655 |
| 9 | MP0000685_abnormal_immune_system | 2.56861328 |
| 10 | MP0008260_abnormal_autophagy | 2.50289155 |
| 11 | MP0002396_abnormal_hematopoietic_system | 2.45935068 |
| 12 | MP0003303_peritoneal_inflammation | 2.43930035 |
| 13 | MP0000751_myopathy | 2.42516479 |
| 14 | MP0004233_abnormal_muscle_weight | 2.36216395 |
| 15 | MP0001849_ear_inflammation | 2.34202378 |
| 16 | MP0003436_decreased_susceptibility_to | 2.32777426 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.28920972 |
| 18 | MP0004858_abnormal_nervous_system | 2.26506235 |
| 19 | MP0003763_abnormal_thymus_physiology | 2.21784134 |
| 20 | MP0005025_abnormal_response_to | 2.21189676 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.20033504 |
| 22 | MP0009333_abnormal_splenocyte_physiolog | 2.19422823 |
| 23 | MP0003453_abnormal_keratinocyte_physiol | 2.14076882 |
| 24 | MP0001800_abnormal_humoral_immune | 2.12165185 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.09866284 |
| 26 | MP0002452_abnormal_antigen_presenting | 2.08322991 |
| 27 | MP0000490_abnormal_crypts_of | 2.07445791 |
| 28 | MP0002723_abnormal_immune_serum | 2.04434502 |
| 29 | MP0003724_increased_susceptibility_to | 2.03017518 |
| 30 | MP0010094_abnormal_chromosome_stability | 2.00646440 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.98167987 |
| 32 | MP0002419_abnormal_innate_immunity | 1.98053833 |
| 33 | MP0001819_abnormal_immune_cell | 1.96318110 |
| 34 | MP0001790_abnormal_immune_system | 1.95516874 |
| 35 | MP0005387_immune_system_phenotype | 1.95516874 |
| 36 | MP0002398_abnormal_bone_marrow | 1.94099574 |
| 37 | MP0000747_muscle_weakness | 1.91293530 |
| 38 | MP0003077_abnormal_cell_cycle | 1.91140297 |
| 39 | MP0008058_abnormal_DNA_repair | 1.86914432 |
| 40 | MP0008057_abnormal_DNA_replication | 1.82209866 |
| 41 | MP0005501_abnormal_skin_physiology | 1.81670094 |
| 42 | MP0001853_heart_inflammation | 1.81038583 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.79930810 |
| 44 | MP0002405_respiratory_system_inflammati | 1.77948574 |
| 45 | MP0003186_abnormal_redox_activity | 1.77934718 |
| 46 | MP0005171_absent_coat_pigmentation | 1.74770659 |
| 47 | MP0006054_spinal_hemorrhage | 1.73257173 |
| 48 | MP0000003_abnormal_adipose_tissue | 1.73226752 |
| 49 | MP0000716_abnormal_immune_system | 1.72655079 |
| 50 | MP0000689_abnormal_spleen_morphology | 1.72430550 |
| 51 | MP0003111_abnormal_nucleus_morphology | 1.72342041 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.72162577 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.72162577 |
| 54 | MP0010155_abnormal_intestine_physiology | 1.71378888 |
| 55 | MP0005666_abnormal_adipose_tissue | 1.70371464 |
| 56 | MP0002722_abnormal_immune_system | 1.69974335 |
| 57 | MP0005464_abnormal_platelet_physiology | 1.67858588 |
| 58 | MP0008007_abnormal_cellular_replicative | 1.65533357 |
| 59 | MP0010234_abnormal_vibrissa_follicle | 1.64224838 |
| 60 | MP0002429_abnormal_blood_cell | 1.61432117 |
| 61 | MP0002089_abnormal_postnatal_growth/wei | 1.55128522 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.54540174 |
| 63 | MP0005075_abnormal_melanosome_morpholog | 1.53824527 |
| 64 | MP0005375_adipose_tissue_phenotype | 1.51453622 |
| 65 | MP0002249_abnormal_larynx_morphology | 1.51371148 |
| 66 | MP0002006_tumorigenesis | 1.49499854 |
| 67 | MP0002132_abnormal_respiratory_system | 1.47705903 |
| 68 | MP0000750_abnormal_muscle_regeneration | 1.47528775 |
| 69 | MP0005058_abnormal_lysosome_morphology | 1.46395153 |
| 70 | MP0000858_altered_metastatic_potential | 1.46230419 |
| 71 | MP0001346_abnormal_lacrimal_gland | 1.45142813 |
| 72 | MP0000465_gastrointestinal_hemorrhage | 1.44490108 |
| 73 | MP0001845_abnormal_inflammatory_respons | 1.44430653 |
| 74 | MP0003656_abnormal_erythrocyte_physiolo | 1.42760486 |
| 75 | MP0000733_abnormal_muscle_development | 1.42675917 |
| 76 | MP0010030_abnormal_orbit_morphology | 1.42065442 |
| 77 | MP0002796_impaired_skin_barrier | 1.41771591 |
| 78 | MP0004808_abnormal_hematopoietic_stem | 1.41178323 |
| 79 | MP0010352_gastrointestinal_tract_polyps | 1.41037057 |
| 80 | MP0001873_stomach_inflammation | 1.40138751 |
| 81 | MP0009379_abnormal_foot_pigmentation | 1.37824349 |
| 82 | MP0006082_CNS_inflammation | 1.37528093 |
| 83 | MP0005409_darkened_coat_color | 1.35819425 |
| 84 | MP0005257_abnormal_intraocular_pressure | 1.35224972 |
| 85 | MP0004147_increased_porphyrin_level | 1.34883785 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.34780285 |
| 87 | MP0000703_abnormal_thymus_morphology | 1.34441324 |
| 88 | MP0000537_abnormal_urethra_morphology | 1.33280607 |
| 89 | MP0001348_abnormal_lacrimal_gland | 1.33093023 |
| 90 | MP0001730_embryonic_growth_arrest | 1.32597597 |
| 91 | MP0000678_abnormal_parathyroid_gland | 1.32104114 |
| 92 | MP0003866_abnormal_defecation | 1.29143247 |
| 93 | MP0008469_abnormal_protein_level | 1.26766392 |
| 94 | MP0002019_abnormal_tumor_incidence | 1.26164656 |
| 95 | MP0008932_abnormal_embryonic_tissue | 1.22397931 |
| 96 | MP0009672_abnormal_birth_weight | 1.20777541 |
| 97 | MP0005330_cardiomyopathy | 1.19683672 |
| 98 | MP0002254_reproductive_system_inflammat | 1.18966648 |
| 99 | MP0004947_skin_inflammation | 1.18929069 |
| 100 | MP0001661_extended_life_span | 1.17613618 |
| 101 | MP0003806_abnormal_nucleotide_metabolis | 1.17271096 |
| 102 | MP0004087_abnormal_muscle_fiber | 1.16538547 |
| 103 | MP0003566_abnormal_cell_adhesion | 1.13494233 |
| 104 | MP0003091_abnormal_cell_migration | 1.11606473 |
| 105 | MP0000313_abnormal_cell_death | 1.11159923 |
| 106 | MP0001533_abnormal_skeleton_physiology | 1.10881029 |
| 107 | MP0002933_joint_inflammation | 1.10376886 |
| 108 | MP0002080_prenatal_lethality | 1.08232267 |
| 109 | MP0003329_amyloid_beta_deposits | 1.07158946 |
| 110 | MP0002095_abnormal_skin_pigmentation | 1.04550516 |
| 111 | MP0004130_abnormal_muscle_cell | 1.01160573 |
| 112 | MP0009931_abnormal_skin_appearance | 1.00057399 |
| 113 | MP0005621_abnormal_cell_physiology | 0.98730028 |
| 114 | MP0003786_premature_aging | 0.98617508 |
| 115 | MP0004510_myositis | 0.95022236 |
| 116 | MP0005083_abnormal_biliary_tract | 0.93383638 |
| 117 | MP0005310_abnormal_salivary_gland | 0.92740849 |
| 118 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90214157 |
| 119 | MP0010630_abnormal_cardiac_muscle | 0.88054306 |
| 120 | MP0005623_abnormal_meninges_morphology | 0.87878754 |
| 121 | MP0000681_abnormal_thyroid_gland | 0.86703559 |
| 122 | MP0003300_gastrointestinal_ulcer | 0.85074343 |
| 123 | MP0010307_abnormal_tumor_latency | 0.84321558 |
| 124 | MP0000343_altered_response_to | 0.83231316 |
| 125 | MP0000350_abnormal_cell_proliferation | 0.82661703 |
| 126 | MP0002060_abnormal_skin_morphology | 0.81832537 |
| 127 | MP0000015_abnormal_ear_pigmentation | 0.81579938 |
| 128 | MP0003448_altered_tumor_morphology | 0.80352142 |
| 129 | MP0001216_abnormal_epidermal_layer | 0.79816975 |
| 130 | MP0001986_abnormal_taste_sensitivity | 0.79463394 |
| 131 | MP0009764_decreased_sensitivity_to | 0.79453322 |
| 132 | MP0003191_abnormal_cellular_cholesterol | 0.78800951 |
| 133 | MP0005380_embryogenesis_phenotype | 0.78249379 |
| 134 | MP0001672_abnormal_embryogenesis/_devel | 0.78249379 |
| 135 | MP0009840_abnormal_foam_cell | 0.78218602 |
| 136 | MP0003984_embryonic_growth_retardation | 0.77011205 |
| 137 | MP0009763_increased_sensitivity_to | 0.75989994 |
| 138 | MP0006036_abnormal_mitochondrial_physio | 0.73398337 |
| 139 | MP0000477_abnormal_intestine_morphology | 0.72342081 |
| 140 | MP0004197_abnormal_fetal_growth/weight/ | 0.71422476 |
| 141 | MP0009278_abnormal_bone_marrow | 0.71153306 |
| 142 | MP0002009_preneoplasia | 0.71041125 |
| 143 | MP0002970_abnormal_white_adipose | 0.70953382 |
| 144 | MP0005384_cellular_phenotype | 0.70486778 |
| 145 | MP0004782_abnormal_surfactant_physiolog | 0.70390228 |
| 146 | MP0002086_abnormal_extraembryonic_tissu | 0.69658851 |
| 147 | MP0002098_abnormal_vibrissa_morphology | 0.69656681 |
| 148 | MP0002088_abnormal_embryonic_growth/wei | 0.68663139 |
| 149 | MP0005023_abnormal_wound_healing | 0.68208245 |
| 150 | MP0000372_irregular_coat_pigmentation | 0.68092965 |
| 151 | MP0002075_abnormal_coat/hair_pigmentati | 0.67925175 |
| 152 | MP0005379_endocrine/exocrine_gland_phen | 0.67264452 |
| 153 | MP0002269_muscular_atrophy | 0.66697652 |
| 154 | MP0003943_abnormal_hepatobiliary_system | 0.66501142 |
| 155 | MP0001764_abnormal_homeostasis | 0.66363858 |
| 156 | MP0000377_abnormal_hair_follicle | 0.63975097 |
| 157 | MP0008438_abnormal_cutaneous_collagen | 0.63663110 |
| 158 | MP0009643_abnormal_urine_homeostasis | 0.62472848 |
| 159 | MP0003634_abnormal_glial_cell | 0.62415735 |
| 160 | MP0002877_abnormal_melanocyte_morpholog | 0.62362757 |
| 161 | MP0003172_abnormal_lysosome_physiology | 0.61906697 |
| 162 | MP0002693_abnormal_pancreas_physiology | 0.61119412 |
| 163 | MP0001663_abnormal_digestive_system | 0.60912831 |
| 164 | MP0005408_hypopigmentation | 0.59004162 |
| 165 | MP0005084_abnormal_gallbladder_morpholo | 0.58925555 |
| 166 | MP0003795_abnormal_bone_structure | 0.58724751 |
| 167 | MP0004381_abnormal_hair_follicle | 0.58446841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.45281512 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.44793911 |
| 3 | Reticulocytopenia (HP:0001896) | 4.77613076 |
| 4 | Recurrent abscess formation (HP:0002722) | 4.40248098 |
| 5 | Ulnar bowing (HP:0003031) | 3.98684156 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.90110273 |
| 7 | Myopathic facies (HP:0002058) | 3.66104675 |
| 8 | Thrombocytosis (HP:0001894) | 3.56349643 |
| 9 | IgM deficiency (HP:0002850) | 3.49560076 |
| 10 | Aplastic anemia (HP:0001915) | 3.49550061 |
| 11 | Chronic otitis media (HP:0000389) | 3.37887574 |
| 12 | Pallor (HP:0000980) | 3.36544448 |
| 13 | Hyperacusis (HP:0010780) | 3.35110542 |
| 14 | Petechiae (HP:0000967) | 3.34523089 |
| 15 | Vacuolated lymphocytes (HP:0001922) | 3.29614357 |
| 16 | Macrocytic anemia (HP:0001972) | 3.26862066 |
| 17 | Hemorrhage of the eye (HP:0011885) | 3.24307515 |
| 18 | Type I transferrin isoform profile (HP:0003642) | 3.17343503 |
| 19 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.17168583 |
| 20 | Vertebral compression fractures (HP:0002953) | 3.06328614 |
| 21 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.01952765 |
| 22 | Broad distal phalanx of finger (HP:0009836) | 2.97810674 |
| 23 | Turricephaly (HP:0000262) | 2.91771822 |
| 24 | Eczematoid dermatitis (HP:0000976) | 2.88896500 |
| 25 | Testicular atrophy (HP:0000029) | 2.85090897 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 2.83115733 |
| 27 | Thin bony cortex (HP:0002753) | 2.80376414 |
| 28 | Achilles tendon contracture (HP:0001771) | 2.79956415 |
| 29 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.79806656 |
| 30 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.79806656 |
| 31 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.78781935 |
| 32 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.78781935 |
| 33 | Abnormal protein glycosylation (HP:0012346) | 2.78781935 |
| 34 | Abnormal glycosylation (HP:0012345) | 2.78781935 |
| 35 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.74022354 |
| 36 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.73941718 |
| 37 | Myositis (HP:0100614) | 2.71365182 |
| 38 | Pustule (HP:0200039) | 2.70633885 |
| 39 | Stridor (HP:0010307) | 2.67087929 |
| 40 | Poor head control (HP:0002421) | 2.65139837 |
| 41 | Upper limb amyotrophy (HP:0009129) | 2.64148290 |
| 42 | Distal upper limb amyotrophy (HP:0007149) | 2.64148290 |
| 43 | Exercise-induced myalgia (HP:0003738) | 2.60404470 |
| 44 | Ragged-red muscle fibers (HP:0003200) | 2.59746335 |
| 45 | 11 pairs of ribs (HP:0000878) | 2.59343260 |
| 46 | Abnormality of macrophages (HP:0004311) | 2.57941290 |
| 47 | Reduced antithrombin III activity (HP:0001976) | 2.54249108 |
| 48 | Birth length less than 3rd percentile (HP:0003561) | 2.52235373 |
| 49 | Recurrent bronchitis (HP:0002837) | 2.52073718 |
| 50 | Increased connective tissue (HP:0009025) | 2.50748413 |
| 51 | Distal lower limb amyotrophy (HP:0008944) | 2.50347392 |
| 52 | Exertional dyspnea (HP:0002875) | 2.50032209 |
| 53 | Progressive muscle weakness (HP:0003323) | 2.47154803 |
| 54 | Abnormality of the Achilles tendon (HP:0005109) | 2.46455283 |
| 55 | Hepatocellular necrosis (HP:0001404) | 2.45598198 |
| 56 | Recurrent skin infections (HP:0001581) | 2.44490631 |
| 57 | Reticulocytosis (HP:0001923) | 2.43006960 |
| 58 | Hepatic necrosis (HP:0002605) | 2.42138439 |
| 59 | Abnormality of the thoracic spine (HP:0100711) | 2.41842513 |
| 60 | 3-Methylglutaconic aciduria (HP:0003535) | 2.40173352 |
| 61 | Oral leukoplakia (HP:0002745) | 2.39989551 |
| 62 | Abnormality of T cells (HP:0002843) | 2.35985786 |
| 63 | Biconcave vertebral bodies (HP:0004586) | 2.35038218 |
| 64 | Agnosia (HP:0010524) | 2.29502711 |
| 65 | Lymphoma (HP:0002665) | 2.28470742 |
| 66 | Distal lower limb muscle weakness (HP:0009053) | 2.28090443 |
| 67 | IgG deficiency (HP:0004315) | 2.27195645 |
| 68 | Recurrent viral infections (HP:0004429) | 2.26287956 |
| 69 | Increased hepatocellular lipid droplets (HP:0006565) | 2.24583666 |
| 70 | Difficulty climbing stairs (HP:0003551) | 2.24409382 |
| 71 | Increased cerebral lipofuscin (HP:0011813) | 2.23897031 |
| 72 | Obstructive lung disease (HP:0006536) | 2.19794759 |
| 73 | Chronic obstructive pulmonary disease (HP:0006510) | 2.19794759 |
| 74 | Long palpebral fissure (HP:0000637) | 2.18698664 |
| 75 | Poikiloderma (HP:0001029) | 2.17879454 |
| 76 | Mediastinal lymphadenopathy (HP:0100721) | 2.16996172 |
| 77 | Cholelithiasis (HP:0001081) | 2.12144595 |
| 78 | Thoracic kyphosis (HP:0002942) | 2.11232438 |
| 79 | Lipid accumulation in hepatocytes (HP:0006561) | 2.11126544 |
| 80 | Meningitis (HP:0001287) | 2.11013545 |
| 81 | Pancytopenia (HP:0001876) | 2.10858997 |
| 82 | Dysostosis multiplex (HP:0000943) | 2.09294569 |
| 83 | Insomnia (HP:0100785) | 2.09239691 |
| 84 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.06253440 |
| 85 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.06253440 |
| 86 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.06253440 |
| 87 | J-shaped sella turcica (HP:0002680) | 2.06251124 |
| 88 | Recurrent fungal infections (HP:0002841) | 2.05181576 |
| 89 | Mitochondrial inheritance (HP:0001427) | 2.05154491 |
| 90 | Hypertensive crisis (HP:0100735) | 2.05047181 |
| 91 | Cervical subluxation (HP:0003308) | 2.05030885 |
| 92 | Squamous cell carcinoma (HP:0002860) | 2.03651802 |
| 93 | Mucopolysacchariduria (HP:0008155) | 2.02320329 |
| 94 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02320329 |
| 95 | Hand muscle atrophy (HP:0009130) | 2.01488293 |
| 96 | Microvesicular hepatic steatosis (HP:0001414) | 2.00657163 |
| 97 | Cerebral aneurysm (HP:0004944) | 1.99356712 |
| 98 | Bulbar palsy (HP:0001283) | 1.98473017 |
| 99 | Polygenic inheritance (HP:0010982) | 1.98200700 |
| 100 | Hepatosplenomegaly (HP:0001433) | 1.97938076 |
| 101 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97864343 |
| 102 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97509582 |
| 103 | Abnormality of reticulocytes (HP:0004312) | 1.97186148 |
| 104 | Neutropenia (HP:0001875) | 1.96772298 |
| 105 | Lymphopenia (HP:0001888) | 1.96436833 |
| 106 | Prolonged bleeding time (HP:0003010) | 1.96122221 |
| 107 | Thin ribs (HP:0000883) | 1.95431131 |
| 108 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.94595093 |
| 109 | Microretrognathia (HP:0000308) | 1.93613849 |
| 110 | Abnormal gallbladder physiology (HP:0012438) | 1.93304774 |
| 111 | Cholecystitis (HP:0001082) | 1.93304774 |
| 112 | Rough bone trabeculation (HP:0100670) | 1.92925345 |
| 113 | Bowed forearm bones (HP:0003956) | 1.92484156 |
| 114 | Bowing of the arm (HP:0006488) | 1.92484156 |
| 115 | Nasal polyposis (HP:0100582) | 1.91659946 |
| 116 | Annular pancreas (HP:0001734) | 1.91359202 |
| 117 | Increased intramyocellular lipid droplets (HP:0012240) | 1.90711441 |
| 118 | Vaginal fistula (HP:0004320) | 1.89970805 |
| 119 | Pulmonary fibrosis (HP:0002206) | 1.88851289 |
| 120 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.88355713 |
| 121 | Abnormality of B cell number (HP:0010975) | 1.88099020 |
| 122 | B lymphocytopenia (HP:0010976) | 1.88099020 |
| 123 | Cellulitis (HP:0100658) | 1.87673463 |
| 124 | Epistaxis (HP:0000421) | 1.86819212 |
| 125 | Increased serum ferritin (HP:0003281) | 1.86146434 |
| 126 | Amaurosis fugax (HP:0100576) | 1.85927040 |
| 127 | Progressive external ophthalmoplegia (HP:0000590) | 1.85844171 |
| 128 | Vasculitis (HP:0002633) | 1.85686537 |
| 129 | Panhypogammaglobulinemia (HP:0003139) | 1.85120183 |
| 130 | Increased IgM level (HP:0003496) | 1.84936282 |
| 131 | Colitis (HP:0002583) | 1.84162636 |
| 132 | Joint stiffness (HP:0001387) | 1.84100340 |
| 133 | Stomatitis (HP:0010280) | 1.83758058 |
| 134 | Flat acetabular roof (HP:0003180) | 1.83326391 |
| 135 | Increased serum lactate (HP:0002151) | 1.82936672 |
| 136 | Bone marrow hypocellularity (HP:0005528) | 1.82500421 |
| 137 | Generalized aminoaciduria (HP:0002909) | 1.82312126 |
| 138 | Abnormality of the fingertips (HP:0001211) | 1.81330413 |
| 139 | Granulocytopenia (HP:0001913) | 1.81307298 |
| 140 | Pointed chin (HP:0000307) | 1.81009540 |
| 141 | Purpura (HP:0000979) | 1.79852939 |
| 142 | Easy fatigability (HP:0003388) | 1.79087852 |
| 143 | Neuronal loss in central nervous system (HP:0002529) | 1.78466026 |
| 144 | Progressive neurologic deterioration (HP:0002344) | 1.78304769 |
| 145 | Ankle clonus (HP:0011448) | 1.78237889 |
| 146 | Abnormality of glycolipid metabolism (HP:0010969) | 1.77976185 |
| 147 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.77976185 |
| 148 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.77976185 |
| 149 | Obstructive sleep apnea (HP:0002870) | 1.77860392 |
| 150 | Autoimmune hemolytic anemia (HP:0001890) | 1.77835663 |
| 151 | Renal Fanconi syndrome (HP:0001994) | 1.77601225 |
| 152 | Nuclear cataract (HP:0100018) | 1.77184935 |
| 153 | Germ cell neoplasia (HP:0100728) | 1.76974446 |
| 154 | Protrusio acetabuli (HP:0003179) | 1.76858451 |
| 155 | Recurrent pneumonia (HP:0006532) | 1.76581870 |
| 156 | Premature graying of hair (HP:0002216) | 1.76245296 |
| 157 | Rectal prolapse (HP:0002035) | 1.75790222 |
| 158 | Premature skin wrinkling (HP:0100678) | 1.75698283 |
| 159 | Gastrointestinal inflammation (HP:0004386) | 1.75648782 |
| 160 | Basal ganglia calcification (HP:0002135) | 1.75483786 |
| 161 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.75127163 |
| 162 | Flared metaphyses (HP:0003015) | 1.75096451 |
| 163 | Increased CSF lactate (HP:0002490) | 1.74686841 |
| 164 | Microcytic anemia (HP:0001935) | 1.74442742 |
| 165 | Diaphragmatic weakness (HP:0009113) | 1.74165774 |
| 166 | Nausea (HP:0002018) | 1.73848051 |
| 167 | Inflammation of the large intestine (HP:0002037) | 1.73797522 |
| 168 | Colon cancer (HP:0003003) | 1.73575043 |
| 169 | Pseudobulbar signs (HP:0002200) | 1.73483130 |
| 170 | Abnormality of T cell number (HP:0011839) | 1.73355832 |
| 171 | Increased muscle lipid content (HP:0009058) | 1.73314014 |
| 172 | T lymphocytopenia (HP:0005403) | 1.73001134 |
| 173 | Loss of speech (HP:0002371) | 1.72484070 |
| 174 | Bowel incontinence (HP:0002607) | 1.72442560 |
| 175 | Back pain (HP:0003418) | 1.72225728 |
| 176 | Increased variability in muscle fiber diameter (HP:0003557) | 1.71875349 |
| 177 | Shallow orbits (HP:0000586) | 1.71246294 |
| 178 | Broad face (HP:0000283) | 1.70998209 |
| 179 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.70595034 |
| 180 | Abnormality of the gallbladder (HP:0005264) | 1.69685547 |
| 181 | Elbow flexion contracture (HP:0002987) | 1.69395986 |
| 182 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69038556 |
| 183 | External ophthalmoplegia (HP:0000544) | 1.69020572 |
| 184 | Abnormal large intestine physiology (HP:0012700) | 1.67730257 |
| 185 | Emphysema (HP:0002097) | 1.66619389 |
| 186 | Dysmetric saccades (HP:0000641) | 1.66398991 |
| 187 | Abnormal gallbladder morphology (HP:0012437) | 1.65489809 |
| 188 | Intestinal fistula (HP:0100819) | 1.65190886 |
| 189 | Spinal cord lesions (HP:0100561) | 1.63917369 |
| 190 | Syringomyelia (HP:0003396) | 1.63917369 |
| 191 | Breast hypoplasia (HP:0003187) | 1.63665773 |
| 192 | Disproportionate tall stature (HP:0001519) | 1.61519368 |
| 193 | Mitral regurgitation (HP:0001653) | 1.61308128 |
| 194 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.60589572 |
| 195 | Generalized amyotrophy (HP:0003700) | 1.59720304 |
| 196 | Choanal stenosis (HP:0000452) | 1.59473545 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 5.09799648 |
| 2 | SMG1 | 4.24608666 |
| 3 | NME2 | 3.30145324 |
| 4 | ICK | 2.98844617 |
| 5 | SIK1 | 2.80546519 |
| 6 | CDK12 | 2.74706201 |
| 7 | PRPF4B | 2.67405132 |
| 8 | MAP4K1 | 2.54601327 |
| 9 | STK16 | 2.52079209 |
| 10 | PIM2 | 2.44534347 |
| 11 | EIF2AK1 | 2.40678363 |
| 12 | TLK1 | 2.39102845 |
| 13 | WEE1 | 2.29640962 |
| 14 | TESK2 | 2.13516589 |
| 15 | VRK1 | 2.10496578 |
| 16 | BUB1 | 2.08525355 |
| 17 | ACVR1B | 1.96780185 |
| 18 | TEC | 1.86310882 |
| 19 | TTN | 1.85006686 |
| 20 | BLK | 1.82023214 |
| 21 | KDR | 1.81783637 |
| 22 | KIT | 1.79468993 |
| 23 | BTK | 1.76853792 |
| 24 | IRAK3 | 1.75324792 |
| 25 | EIF2AK3 | 1.73682165 |
| 26 | IRAK4 | 1.73640187 |
| 27 | ZAP70 | 1.73094792 |
| 28 | TBK1 | 1.68226560 |
| 29 | FLT3 | 1.60139344 |
| 30 | TYK2 | 1.56211205 |
| 31 | DYRK3 | 1.53946199 |
| 32 | MAP2K3 | 1.52294544 |
| 33 | IKBKB | 1.48392905 |
| 34 | PASK | 1.46555863 |
| 35 | RPS6KB2 | 1.46218439 |
| 36 | BRSK2 | 1.45759714 |
| 37 | RPS6KA4 | 1.42578508 |
| 38 | TXK | 1.37702069 |
| 39 | CDC7 | 1.34882683 |
| 40 | MST4 | 1.34877698 |
| 41 | FGFR4 | 1.31651349 |
| 42 | LRRK2 | 1.31304901 |
| 43 | RIPK1 | 1.31196989 |
| 44 | MAP3K14 | 1.29904771 |
| 45 | IKBKE | 1.29846482 |
| 46 | JAK3 | 1.25501056 |
| 47 | MAP3K11 | 1.25222289 |
| 48 | PKN2 | 1.24785963 |
| 49 | VRK2 | 1.22671005 |
| 50 | CLK1 | 1.22546211 |
| 51 | STK10 | 1.21430201 |
| 52 | TESK1 | 1.18871895 |
| 53 | PIM1 | 1.18701611 |
| 54 | PRKD3 | 1.18308767 |
| 55 | MAPKAPK3 | 1.16200598 |
| 56 | SRPK1 | 1.15347215 |
| 57 | TAOK2 | 1.14123780 |
| 58 | ERN1 | 1.13456287 |
| 59 | EPHA2 | 1.10299458 |
| 60 | RPS6KA2 | 1.09622507 |
| 61 | MTOR | 1.09040865 |
| 62 | PBK | 1.08589206 |
| 63 | STK4 | 1.02634379 |
| 64 | CDK7 | 1.02032440 |
| 65 | PDPK1 | 0.98701950 |
| 66 | MAPK11 | 0.98265281 |
| 67 | CSF1R | 0.96979602 |
| 68 | PLK4 | 0.96432807 |
| 69 | NEK2 | 0.96231771 |
| 70 | RPS6KL1 | 0.95972612 |
| 71 | RPS6KC1 | 0.95972612 |
| 72 | AURKB | 0.94580460 |
| 73 | LYN | 0.94541803 |
| 74 | IRAK2 | 0.93761014 |
| 75 | SYK | 0.93516272 |
| 76 | RPS6KA5 | 0.92901586 |
| 77 | NLK | 0.92400234 |
| 78 | MAP3K10 | 0.90440647 |
| 79 | BCKDK | 0.90410208 |
| 80 | MAP3K3 | 0.88993095 |
| 81 | ATR | 0.88595124 |
| 82 | ITK | 0.87163151 |
| 83 | EIF2AK2 | 0.81568801 |
| 84 | BMX | 0.80201149 |
| 85 | LCK | 0.79969683 |
| 86 | BRAF | 0.79272027 |
| 87 | TGFBR2 | 0.79086275 |
| 88 | MAP2K2 | 0.77936159 |
| 89 | MAPK15 | 0.77153549 |
| 90 | PRKD2 | 0.75948543 |
| 91 | TGFBR1 | 0.75864130 |
| 92 | SCYL2 | 0.75613358 |
| 93 | PDGFRA | 0.74947789 |
| 94 | PTK6 | 0.73889173 |
| 95 | MAP3K8 | 0.73270747 |
| 96 | TAOK1 | 0.73213060 |
| 97 | MARK2 | 0.71144686 |
| 98 | MAP2K6 | 0.71131119 |
| 99 | MATK | 0.70272349 |
| 100 | CDK9 | 0.70177579 |
| 101 | PIK3CG | 0.69848050 |
| 102 | SIK2 | 0.69242504 |
| 103 | CCNB1 | 0.68292119 |
| 104 | CAMK1D | 0.68250723 |
| 105 | PLK1 | 0.67625866 |
| 106 | BRSK1 | 0.66507252 |
| 107 | MAP3K1 | 0.66289702 |
| 108 | CDK8 | 0.65434479 |
| 109 | ZAK | 0.65131913 |
| 110 | MAP3K13 | 0.64531345 |
| 111 | ILK | 0.64159605 |
| 112 | GRK6 | 0.63146236 |
| 113 | MAPKAPK5 | 0.62722482 |
| 114 | CDK6 | 0.61925372 |
| 115 | AKT2 | 0.60689132 |
| 116 | TNK2 | 0.59908732 |
| 117 | PAK4 | 0.58320366 |
| 118 | MKNK1 | 0.56983569 |
| 119 | CDK4 | 0.56638563 |
| 120 | MST1R | 0.55968130 |
| 121 | MAPK12 | 0.55005123 |
| 122 | CDK19 | 0.54362692 |
| 123 | CDC42BPA | 0.54120098 |
| 124 | IRAK1 | 0.52993479 |
| 125 | CHUK | 0.51908579 |
| 126 | EEF2K | 0.51613108 |
| 127 | KSR2 | 0.51491202 |
| 128 | CHEK2 | 0.49172116 |
| 129 | TRPM7 | 0.48249957 |
| 130 | NEK9 | 0.47840397 |
| 131 | DAPK3 | 0.47038294 |
| 132 | TAOK3 | 0.46914746 |
| 133 | RPS6KA6 | 0.46717184 |
| 134 | ARAF | 0.46337517 |
| 135 | PRKG2 | 0.45963070 |
| 136 | PDK1 | 0.45818615 |
| 137 | MAP3K9 | 0.45804805 |
| 138 | CSK | 0.45492637 |
| 139 | CSNK2A1 | 0.44173227 |
| 140 | AURKA | 0.43817646 |
| 141 | MAP3K12 | 0.43527310 |
| 142 | MAPKAPK2 | 0.42434329 |
| 143 | HIPK2 | 0.41558914 |
| 144 | MAP3K6 | 0.40940532 |
| 145 | RPS6KA1 | 0.40664551 |
| 146 | LMTK2 | 0.40661702 |
| 147 | MUSK | 0.39152201 |
| 148 | CDK11A | 0.37913666 |
| 149 | PAK1 | 0.37664102 |
| 150 | TYRO3 | 0.37588038 |
| 151 | BRD4 | 0.36570521 |
| 152 | DAPK1 | 0.35623785 |
| 153 | DYRK1B | 0.35159842 |
| 154 | CDK15 | 0.34595091 |
| 155 | MAPK4 | 0.32650858 |
| 156 | CHEK1 | 0.32262278 |
| 157 | DDR2 | 0.31313488 |
| 158 | PRKD1 | 0.30797092 |
| 159 | PTK2 | 0.30487119 |
| 160 | LATS2 | 0.30117433 |
| 161 | CDK2 | 0.28454476 |
| 162 | RIPK4 | 0.27136910 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.52464655 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 4.03896623 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.09771544 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 2.82101620 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.60899027 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.57795067 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.54976677 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.46604937 |
| 9 | RNA polymerase_Homo sapiens_hsa03020 | 2.31808156 |
| 10 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 2.22015868 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19021616 |
| 12 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 2.15108670 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.14495057 |
| 14 | Bladder cancer_Homo sapiens_hsa05219 | 2.11040249 |
| 15 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.08783187 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 2.04673392 |
| 17 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.87019592 |
| 18 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.81786520 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.73536066 |
| 20 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.73154048 |
| 21 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.72347926 |
| 22 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.68577064 |
| 23 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66775600 |
| 24 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.65296843 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.64118634 |
| 26 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.60873131 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.54528740 |
| 28 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.49706802 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48000387 |
| 30 | Other glycan degradation_Homo sapiens_hsa00511 | 1.46380480 |
| 31 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.44768609 |
| 32 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.44229425 |
| 33 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.42880230 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.41152416 |
| 35 | Cell cycle_Homo sapiens_hsa04110 | 1.33108725 |
| 36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31697648 |
| 37 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.31213209 |
| 38 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.30220625 |
| 39 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.29063198 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.28230950 |
| 41 | RNA transport_Homo sapiens_hsa03013 | 1.26653939 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.26563701 |
| 43 | Lysine degradation_Homo sapiens_hsa00310 | 1.26225975 |
| 44 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.25568899 |
| 45 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24954920 |
| 46 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.23884213 |
| 47 | Alcoholism_Homo sapiens_hsa05034 | 1.22266657 |
| 48 | Leishmaniasis_Homo sapiens_hsa05140 | 1.21809012 |
| 49 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.20796989 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19213576 |
| 51 | Allograft rejection_Homo sapiens_hsa05330 | 1.18631928 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 1.18442819 |
| 53 | * Basal transcription factors_Homo sapiens_hsa03022 | 1.17790714 |
| 54 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17129202 |
| 55 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.16676893 |
| 56 | Prion diseases_Homo sapiens_hsa05020 | 1.15082678 |
| 57 | Measles_Homo sapiens_hsa05162 | 1.14360245 |
| 58 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.12897580 |
| 59 | Endometrial cancer_Homo sapiens_hsa05213 | 1.12043743 |
| 60 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.11460750 |
| 61 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.10843250 |
| 62 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.08860192 |
| 63 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.08824300 |
| 64 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06707476 |
| 65 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05500929 |
| 66 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 1.03486801 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.03439497 |
| 68 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.01676711 |
| 69 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.01639975 |
| 70 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.00375028 |
| 71 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99633159 |
| 72 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.98693764 |
| 73 | Parkinsons disease_Homo sapiens_hsa05012 | 0.97420952 |
| 74 | Purine metabolism_Homo sapiens_hsa00230 | 0.97290301 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.96311837 |
| 76 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95951806 |
| 77 | Thyroid cancer_Homo sapiens_hsa05216 | 0.95673501 |
| 78 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94547620 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.92911665 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.90301620 |
| 81 | Apoptosis_Homo sapiens_hsa04210 | 0.88486575 |
| 82 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88315575 |
| 83 | Glioma_Homo sapiens_hsa05214 | 0.86678344 |
| 84 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.86547420 |
| 85 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.86453474 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85083234 |
| 87 | Shigellosis_Homo sapiens_hsa05131 | 0.81073758 |
| 88 | Malaria_Homo sapiens_hsa05144 | 0.81022049 |
| 89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.80323538 |
| 90 | Pertussis_Homo sapiens_hsa05133 | 0.80123534 |
| 91 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.79372023 |
| 92 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.78767276 |
| 93 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.78396156 |
| 94 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.75226913 |
| 95 | Lysosome_Homo sapiens_hsa04142 | 0.75104593 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.74956399 |
| 97 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.73868322 |
| 98 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.73433103 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72812784 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.71316744 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.71256648 |
| 102 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71171748 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71091412 |
| 104 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.70432220 |
| 105 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69917018 |
| 106 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69815885 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.67630463 |
| 108 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66619633 |
| 109 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.66381757 |
| 110 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.66313958 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65813359 |
| 112 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64751924 |
| 113 | Insulin resistance_Homo sapiens_hsa04931 | 0.64593231 |
| 114 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.63669539 |
| 115 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.62605097 |
| 116 | Influenza A_Homo sapiens_hsa05164 | 0.62019861 |
| 117 | Prostate cancer_Homo sapiens_hsa05215 | 0.60910294 |
| 118 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60034049 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.59288928 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58558700 |
| 121 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.58332782 |
| 122 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.57267749 |
| 123 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.57192086 |
| 124 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.56796808 |
| 125 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55879966 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.54607167 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54541260 |
| 128 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.53702313 |
| 129 | Hepatitis B_Homo sapiens_hsa05161 | 0.53483041 |
| 130 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.53424138 |
| 131 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.52791097 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.52709422 |
| 133 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.52679347 |
| 134 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52174932 |
| 135 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.52035003 |
| 136 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.50248072 |
| 137 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50036839 |
| 138 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.49975466 |
| 139 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49319549 |
| 140 | Tuberculosis_Homo sapiens_hsa05152 | 0.49205226 |
| 141 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.47519964 |
| 142 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.46370253 |
| 143 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.46274129 |
| 144 | Salmonella infection_Homo sapiens_hsa05132 | 0.45440641 |
| 145 | HTLV-I infection_Homo sapiens_hsa05166 | 0.45289444 |
| 146 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44999926 |
| 147 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.44941057 |
| 148 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.44208409 |
| 149 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.43857031 |
| 150 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43794312 |
| 151 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.42653072 |
| 152 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.42579589 |
| 153 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41461924 |
| 154 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.40373575 |
| 155 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.37806973 |
| 156 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.37649599 |
| 157 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.37137880 |
| 158 | Galactose metabolism_Homo sapiens_hsa00052 | 0.37116955 |
| 159 | Metabolic pathways_Homo sapiens_hsa01100 | 0.36658235 |
| 160 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.35401176 |
| 161 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33852420 |
| 162 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.31575116 |
| 163 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31308414 |
| 164 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29957771 |
| 165 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.29320231 |

